Rigacci, Luigi
 Distribuzione geografica
Continente #
NA - Nord America 2.533
EU - Europa 1.510
AS - Asia 913
SA - Sud America 103
AF - Africa 31
OC - Oceania 13
Totale 5.103
Nazione #
US - Stati Uniti d'America 2.506
RU - Federazione Russa 694
SG - Singapore 277
HK - Hong Kong 202
PL - Polonia 198
CN - Cina 195
IT - Italia 151
IE - Irlanda 139
SE - Svezia 97
BR - Brasile 88
KR - Corea 79
DE - Germania 74
FI - Finlandia 45
CH - Svizzera 42
IN - India 41
VN - Vietnam 35
JO - Giordania 28
GB - Regno Unito 23
CA - Canada 19
AU - Australia 13
FR - Francia 11
ID - Indonesia 11
TR - Turchia 9
JP - Giappone 8
ZA - Sudafrica 8
AR - Argentina 6
CI - Costa d'Avorio 6
MA - Marocco 6
NL - Olanda 6
AT - Austria 5
BD - Bangladesh 5
MX - Messico 5
UA - Ucraina 5
LT - Lituania 4
PK - Pakistan 4
TN - Tunisia 4
PT - Portogallo 3
RO - Romania 3
VE - Venezuela 3
BE - Belgio 2
BJ - Benin 2
DK - Danimarca 2
EC - Ecuador 2
EG - Egitto 2
ES - Italia 2
IQ - Iraq 2
OM - Oman 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BO - Bolivia 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TJ - Tagikistan 1
UY - Uruguay 1
Totale 5.103
Città #
Santa Clara 639
Ashburn 319
Fairfield 204
Warsaw 195
Hong Kong 167
Singapore 162
Chandler 141
Dublin 139
Seattle 124
Woodbridge 101
Cambridge 91
Houston 87
Seoul 78
Wilmington 72
Beijing 69
Ann Arbor 49
Munich 44
Bern 41
Buffalo 39
Lawrence 38
Altamura 37
Florence 33
Princeton 33
Los Angeles 32
Moscow 31
Hefei 26
Mumbai 25
Boston 23
Kent 23
Dallas 19
San Diego 17
Shanghai 17
Helsinki 15
New York 15
Boardman 14
Clifton 13
Lappeenranta 13
Medford 13
Melbourne 12
Ho Chi Minh City 11
Bremen 10
Norwalk 9
Jakarta 8
Montreal 8
Paris 8
The Dalles 8
Tokyo 8
Hanoi 7
Johannesburg 7
Milan 7
São Paulo 7
Toronto 7
Abidjan 6
Dong Ket 6
Falkenstein 6
London 6
Redondo Beach 6
Tianjin 6
Turku 6
Denver 5
Jacksonville 5
Salerno 5
Sesto Fiorentino 5
Bologna 4
Chennai 4
Dearborn 4
Falls Church 4
Guangzhou 4
Orem 4
Phoenix 4
Pune 4
Andover 3
Casablanca 3
Cerea 3
Charlotte 3
Curitiba 3
Frankfurt am Main 3
Hải Dương 3
Izmir 3
Latina 3
Olgiate Olona 3
Poplar 3
Redwood City 3
Rio de Janeiro 3
Rome 3
Stockholm 3
Timisoara 3
Washington 3
Amman 2
Amsterdam 2
Annapolis 2
Aversa 2
Bengaluru 2
Brooklyn 2
Brussels 2
Chengdu 2
Chicago 2
Cincinnati 2
Copenhagen 2
Cotonou 2
Totale 3.484
Nome #
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience 280
MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients 235
Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study 224
The ion channels and transporters gene expression profile indicates a shift in excitability and metabolisms during malignant progression of Follicular Lymphoma 207
Baseline metabolic tumor volume calculation using different SUV thresholding methods in Hodgkin lymphoma patients: Interobserver agreement and reproducibility across software platforms 188
Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity 180
THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 177
Focal spleen lesions in visceral leishmaniasis, a neglected manifestation of a neglected disease: report of three cases and systematic review of literature 176
Identification Of Pharmacogenomic Markers Of Clinical Efficacy In A Dose-Dense Therapy Regimen (R-Chop14) In Diffuse Large B Cell Lymphoma 171
Role of core needle biopsy in primary breast lymphoma 169
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 168
Diffusion-Weighted and Perfusion-Weighted MRI to Evaluate Therapeutic Response in Lymphoma: A Comparison with FDG-PET/CT 168
Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study 167
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment 166
Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma 164
CLINICAL CHARACTERISTICS OF PATIENTS WITH NEGATIVE INTERIM-PET AND POSITIVE FINAL PET: DATA FROM THE PROSPECTIVE PET-ORIENTED HD0801 STUDY BY FONDAZIONE ITALIANA LINFOMI (FIL) 162
A gene expression-based model to predict metabolic response after two courses of ABVD in Hodgkin Lymphoma patients 162
Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis. 157
Romiplostim before splenectomy in a patient with aggressive non-Hodgkin lymphoma and poor response to platelet transfusions 156
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 152
Feasibility and safety of a reduced duration of therapy of colony-stimulating factor in a dose-dense regimen 149
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV 145
The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL) 145
Aggressive Disease Course of Multiple Myeloma with Concomitant ALK-Negative Anaplastic Large Cell Lymphoma: A Case Report with an Unusual Presentation 137
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study. 130
Treatment and prognosis of primary pulmonary lymphoma: a long-term follow-up study 128
Pharmacogenomic Markers of Clinical Efficacy in a Dose-Dense Therapy Regimen (R-CHOP14) in Diffuse Large B Cell Lymphoma 128
CMV AND EBV REACTIVATION AFTER AUTOLOGOUS HAEMOPOIETIC STEM CELL TRANSPLANTATION WITH BEAM CONDITIONING REGIMEN FOR MULTIPLE SCLEROSIS AND LYMPHOMA: A RETROSPECTIVE SINGLE CENTER CASE-CONTROL STUDY 126
Single dose palonosetron and dexamethasone in preventing nausea and vomiting induced by high emetogenic ABVD regimen in Hodgkin Lymphoma patients. 112
Pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B cell lymphoma: preliminary results 109
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 106
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 102
Totale 5.146
Categoria #
all - tutte 15.277
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.277


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021254 0 0 0 0 0 32 26 42 33 71 28 22
2021/2022242 1 12 29 17 9 10 14 20 21 11 38 60
2022/2023662 47 120 36 45 37 105 80 43 84 7 11 47
2023/2024296 7 29 34 7 35 38 6 72 7 18 32 11
2024/20251.822 54 180 108 343 529 266 16 84 73 44 60 65
2025/20261.000 262 225 111 136 242 24 0 0 0 0 0 0
Totale 5.146